SCHEMBL29469841

SCHEMBL29469841

Cc1ccc(OC(C)C)c(S(N)(=O)=O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.47
CA2 P00918 3/20 0.47
CA9 Q16790 3/20 0.47
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
ADRA1D P25100 2/20 0.41
ADRA1A P35348 2/20 0.41
ADRA1B P35368 2/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
POLB P06746 2/20 0.41
NPC1 O15118 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
ATM Q13315 1/20 0.41
PKM P14618 2/20 0.41
USP2 O75604 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29469796 1.00 CA1 (0.47) CA1CA2CA9KDM4EALDH1A1
SCHEMBL12180748 0.84 CA1 (0.44) CA1CA2CA9ADRA1DADRA1A
SCHEMBL29469838 0.84 CA1 (0.42) CA1CA2CA9KDM4EALDH1A1
SCHEMBL29469899 0.81 SMN1; SMN2 (0.41) CA1CA2CA9ALDH1A1ADRA1D
SCHEMBL31536845 0.80 KMT2A (0.60) CA1CA2CA9ALDH1A1KMT2A
SCHEMBL5188196 0.80 KMT2A (0.60) CA1CA2CA9ALDH1A1KMT2A
SCHEMBL22588315 0.80 CA1 (0.53) CA1CA2CA9ALDH1A1ADRA1D
SCHEMBL27382367 0.79 CA2 (0.50) CA1CA2CA9KDM4EALDH1A1
SCHEMBL29469865 0.77 PTGES2 (0.55) CA1CA2CA9ALDH1A1ADRA1D
SCHEMBL2247901 0.77 PTGES2 (0.55) CA1CA2CA9ALDH1A1ADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed